Page last updated: 2024-08-16

ribavirin and Flaviviridae Infections

ribavirin has been researched along with Flaviviridae Infections in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alves, MP; Ebert, N; Engler, O; García-Nicolás, O; Gaschen, V; Pfaender, S; Pietschmann, T; Portmann, J; Schweizer, M; Stalder, H; Stoffel, M; Summerfield, A; Thiel, V; Todt, D; V'kovski, P; Vielle, NJ; Vieyres, G; Züst, R	1
Bani-Sadr, F; Cacoub, P; Carrat, F; Goderel, I; Larrat, S; Lunel-Fabiani, F; Martha, B; Morand, P; Payan, C; Perronne, C; Piroth, L; Pol, S	1
Aydin, I; Ferenci, P; Hofer, H; Mueller, C; Neumueller-Guber, S; Scherzer, TM; Staufer, K; Steindl-Munda, P; Wrba, F	1
Fukuda, Y; Hayashi, K; Nakano, I; Takamatsu, J; Toyoda, H	1

Reviews

1 review(s) available for ribavirin and Flaviviridae Infections

Article	Year
[Impact of HIV on HCV, GBV-C/HGV, and HBV infection]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:4 Topics: Anti-HIV Agents; Antibiosis; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Flaviviridae Infections; GB virus C; Hemophilia A; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; HIV-1; Humans; Interferons; Lamivudine; Liver Neoplasms; Liver Transplantation; Prognosis; Ribavirin	2002

Article

Year

[Impact of HIV on HCV, GBV-C/HGV, and HBV infection].

Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:4

Topics: Anti-HIV Agents; Antibiosis; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Flaviviridae Infections; GB virus C; Hemophilia A; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; HIV-1; Humans; Interferons; Lamivudine; Liver Neoplasms; Liver Transplantation; Prognosis; Ribavirin

2002

Trials

1 trial(s) available for ribavirin and Flaviviridae Infections

Article	Year
Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy. Journal of hepatology, 2008, Volume: 49, Issue:6 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; DNA Virus Infections; Drug Therapy, Combination; Female; Flaviviridae Infections; GB virus C; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Torque teno virus; Virus Diseases	2008

Article

Year

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.

Journal of hepatology, 2008, Volume: 49, Issue:6

Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; DNA Virus Infections; Drug Therapy, Combination; Female; Flaviviridae Infections; GB virus C; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Torque teno virus; Virus Diseases

2008

Other Studies

2 other study(ies) available for ribavirin and Flaviviridae Infections

Article	Year
The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:11 Topics: Aedes; Animals; Antiviral Agents; Cell Line; Cell Membrane; Chlorocebus aethiops; Flaviviridae; Flaviviridae Infections; Humans; Interferon-alpha; Ribavirin; RNA, Viral; Vero Cells; Virus Replication	2018
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. Journal of viral hepatitis, 2011, Volume: 18, Issue:7 Topics: Adolescent; Adult; Aged; Antiviral Agents; Coinfection; Female; Flaviviridae Infections; GB virus C; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome	2011

Article

Year

The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor.

Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:11

Topics: Aedes; Animals; Antiviral Agents; Cell Line; Cell Membrane; Chlorocebus aethiops; Flaviviridae; Flaviviridae Infections; Humans; Interferon-alpha; Ribavirin; RNA, Viral; Vero Cells; Virus Replication

2018

Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.

Journal of viral hepatitis, 2011, Volume: 18, Issue:7

Topics: Adolescent; Adult; Aged; Antiviral Agents; Coinfection; Female; Flaviviridae Infections; GB virus C; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome

2011